INTC vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

INTC

38.4
AI Score
VS
INTC Wins

MRNA

34.3
AI Score

Investment Advisor Scores

INTC

38score
Recommendation
SELL

MRNA

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric INTC MRNA Winner
Revenue 29.70B 534.00M INTC
Net Income -14.76B -2.13B MRNA
Net Margin -49.7% -397.9% INTC
Operating Income -1.34B -2.20B INTC
ROE -16.9% -31.4% INTC
ROA -7.3% -19.4% INTC
Total Assets 202.44B 10.96B INTC
Cash 12.87B 1.72B INTC
Debt/Equity 0.55 0.09 MRNA
Current Ratio 1.60 2.29 MRNA
Free Cash Flow 1.91B -1.25B INTC

Relative Price Performance (Last 90 Days)

INTC 1M: +8.3% · 3M: +0.5% MRNA 1M: +40.0% · 3M: +156.6%

Current Technical Phase

INTC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 52

RSI (14): 52.1 · Price: $113.12

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (49.6% over 20 days), RSI 64

RSI (14): 63.6 · Price: $196.48

Fundamentals Snapshot

Metric INTC MRNA
Market Cap — —
Forward P/E 54.3 -41.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.4% -0.7%
Operating Margin 0.1% -5.6%
EPS -2.12 -7.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INTC is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.